AM-Pharma, founded in 2001 and headquartered in Utrecht, the Netherlands, is a late-stage clinical development and pharmaceutical manufacturing company specializing in sepsis-associated acute kidney injury.
| Website | http://www.am-pharma.com |
| Revenue | $7 million |
| Employees | View employees |
| Founded | 2001 |
| Address | 6 Stadsplateau, Utrecht, Utrecht, NL |
| Phone | +31 30 228 9222 |
| Fax | +31 30 228 9220 |
| Industry | Manufacturing General, Drug Discovery, Manufacturing, Pharmaceuticals |
| Web Rank | 7 Million |
| Keywords | Am-Pharma, Recap, Am Pharma, Erik Van Den Berg, Van Den Berg |
| Competitors | Novartis, Roche, Takeda, Amgen, Bristol Myers Squibb, Pfizer, Johnson & Johnson, Regeneron, Receptos, a wholly-owned subsidiary of Celgene, Gilead Sciences +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies |
Looking for a particular AM-Pharma B.V employee's phone or email?
AM-Pharma B.V Questions
The AM-Pharma B.V annual revenue was $7 million in 2026.
AM-Pharma B.V is based in Utrecht, Utrecht.
The NAICS codes for AM-Pharma B.V are [5417, 54, 54171, 541711, 325, 541, 32].
The SIC codes for AM-Pharma B.V are [28, 283, 2834].
Related Companies
G2Crowd Trusted
300K+
Plugin Users
